Public Sector Pension Investment Board Biogen Inc. Transaction History

Public Sector Pension Investment Board

$18.3 Billion
Q3 2024

A detailed history of Public Sector Pension Investment Board transactions in Biogen Inc. stock. As of the latest transaction made, Public Sector Pension Investment Board holds 6,361 shares of BIIB stock, worth $880,680. This represents 0.01% of its overall portfolio holdings.

Number of Shares

6,361

Previous 5,661 12.37%

Holding current value

$880,680

Previous $1.31 Million 6.02%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $132,349 - $165,760	700 Added 12.37%	6,361 $1.23 Million
Q2 2024 Aug 14, 2024	BUY	$190.52 - $236.72 $469,631 - $583,514	2,465 Added 77.13%	5,661 $1.31 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $21,202 - $26,770	-100 Reduced 3.03%	3,196 $689,000
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $2.73 Million - $3.28 Million	-12,254 Reduced 78.8%	3,296 $852,000
Q3 2023 Nov 22, 2023	BUY	$253.3 - $285.89 $428,077 - $483,154	1,690 Added 12.19%	15,550 $4 Million
Q2 2023 Aug 14, 2023	SELL	$275.25 - $318.06 $546,096 - $631,031	-1,984 Reduced 12.52%	13,860 $3.95 Million
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $550,834 - $627,653	-2,147 Reduced 11.93%	15,844 $4.41 Million
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $591,719 - $718,951	2,344 Added 14.98%	17,991 $4.98 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $313,450 - $432,220	1,610 Added 11.47%	15,647 $4.18 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $1.22 Million - $1.45 Million	-6,509 Reduced 31.68%	14,037 $2.86 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $767,329 - $966,794	-3,960 Reduced 16.16%	20,546 $4.33 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $12 Million - $15.4 Million	-53,473 Reduced 68.57%	24,506 $5.88 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $15.4 Million - $20.1 Million	54,373 Added 230.34%	77,979 $22.1 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $2.38 Million - $3.82 Million	9,200 Added 63.86%	23,606 $8.17 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $475,453 - $557,020	1,957 Added 15.72%	14,406 $4.03 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $1.66 Million - $2.5 Million	-7,041 Reduced 36.13%	12,449 $3.05 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $882,478 - $1.02 Million	3,333 Added 20.63%	19,490 $5.53 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $496,368 - $657,353	-1,919 Reduced 10.62%	16,157 $4.32 Million
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $3.56 Million - $4.52 Million	-13,240 Reduced 42.28%	18,076 $5.72 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $981,467 - $1.36 Million	-4,460 Reduced 12.47%	31,316 $9.29 Million
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $2.27 Million - $2.55 Million	10,448 Added 41.25%	35,776 $8.33 Million
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $2.76 Million - $3.05 Million	-12,600 Reduced 33.22%	25,328 $5.92 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $4.38 Million - $6.85 Million	20,200 Added 113.94%	37,928 $8.97 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $2.31 Million - $2.93 Million	8,300 Added 88.04%	17,728 $5.34 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $2.08 Million - $2.73 Million	-7,100 Reduced 42.96%	9,428 $3.33 Million
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $77,256 - $92,073	300 Added 1.85%	16,528 $4.8 Million
Q1 2018 May 10, 2018	SELL	$260.13 - $367.91 $1.95 Million - $2.76 Million	-7,500 Reduced 31.61%	16,228 $4.44 Million
Q4 2017 Feb 02, 2018	SELL	$307.64 - $344.58 $9.23 Million - $10.3 Million	-30,000 Reduced 55.84%	23,728 $7.56 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $15.1 Million - $17.7 Million	53,728	53,728 $0

Others Institutions Holding BIIB

# of Institutions

996

Shares Held

129M

Call Options Held

1.37M

Put Options Held

1.51M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $19.9B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Public Sector Pension Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on Public Sector Pension Investment Board with notifications on news.

Account

Public Sector Pension Investment Board Biogen Inc. Transaction History